Published: 30 Apr 2023 | Report Code: 10248390 | Pages: 198
Europe Active Pharmaceutical Ingredients (API) Market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 91 tables and 76 figures, this 198-page report “Europe Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe Active Pharmaceutical Ingredients (API) Market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include the identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Five Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe Active Pharmaceutical Ingredients (API) Market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Molecule, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o By Type
o Monoclonal Antibodies
o Recombinant Proteins
o Vaccines
o Other Biotech APIs
o By Category
o Innovative Biologic API
o Generic Biosimilar API
o By Expression
o Mammalian Expression
o Microbial Expression
o Yeast Expression
o Insect Expression
o Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o By Drug Type
o Branded Merchant API
o Generic Merchant API
o By Drug Synthesis
o Merchant Synthetic API
o Merchant Biotech API
By Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included. The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents: 1 Introduction 9 1.1 Industry Definition and Research Scope 9 1.1.1 Industry Definition 9 1.1.2 Research Scope 10 1.2 Research Methodology 13 1.2.1 Overview of Market Research Methodology 13 1.2.2 Market Assumption 14 1.2.3 Secondary Data 14 1.2.4 Primary Data 14 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 21 2.1 Market Size and Forecast 21 2.1.1 Impact of COVID-19 on World Economy 22 2.1.2 Impact of COVID-19 on the Market 25 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 32 2.2 Major Growth Drivers 36 2.3 Market Restraints and Challenges 44 2.4 Emerging Opportunities and Market Trends 47 2.5 Porter’s Fiver Forces Analysis 51 3 Segmentation of Europe Market by Molecule 55 3.1 Market Overview by Molecule 55 3.2 Small Molecule APIs 57 3.3 Large Molecule APIs 58 4 Segmentation of Europe Market by Synthesis 59 4.1 Market Overview by Synthesis 59 4.2 Synthetic API 61 4.2.1 Branded Synthetic API 62 4.2.2 Generic Synthetic API 63 4.3 Biotech API 64 4.3.1 Biotech API by Drug Type 65 4.3.1.1 Monoclonal Antibodies 66 4.3.1.2 Recombinant Proteins 67 4.3.1.3 Vaccines 68 4.3.1.4 Other Biotech APIs 69 4.3.2 Biotech API by Category 70 4.3.2.1 Innovative Biologic API 71 4.3.2.2 Generic Biosimilar API 72 4.3.3 Biotech API by Expression Technology 73 4.3.3.1 Mammalian Expression 74 4.3.3.2 Microbial Expression 75 4.3.3.3 Yeast Expression 76 4.3.3.4 Insect Expression 77 4.3.3.5 Other Expression Technologies 78 4.4 HPAPI 79 4.4.1 Branded HPAPI 80 4.4.2 Generic HPAPI 81 5 Segmentation of Europe Market by Manufacturing Process 82 5.1 Market Overview by Manufacturing Process 82 5.2 Captive Manufacturing 84 5.2.1 Branded Captive API 85 5.2.2 Generic Captive API 86 5.3 Merchant Manufacturing 87 5.3.1 Merchant Manufacturing by Drug Type 88 5.3.1.1 Branded Merchant API 89 5.3.1.2 Generic Merchant API 90 5.3.2 Merchant Manufacturing by Drug Synthesis 91 5.3.2.1 Merchant Synthetic API 92 5.3.2.2 Merchant Biotech API 93 6 Segmentation of Europe Market by Therapeutic Application 94 6.1 Market Overview by Therapeutic Application 94 6.2 Infectious Diseases 96 6.3 Oncology 97 6.4 Ophthalmology 98 6.5 Cardiovascular Disorders 99 6.6 Central Nervous System 100 6.7 Pulmonary Disorders 101 6.8 Orthopedics 102 6.9 Other Applications 103 7 Segmentation of Europe Market by Drug Type 104 7.1 Market Overview by Drug Type 104 7.2 Branded Prescription Drugs 106 7.3 Generic Prescription Drugs 107 7.4 OTC Drugs 108 8 European Market 2022-2032 by Country 109 8.1 Overview of European Market 109 8.2 UK 112 8.3 France 114 8.4 Germany 116 8.5 Spain 119 8.6 Italy 121 8.7 Russia 123 8.8 Rest of European Market 125 9 Competitive Landscape 127 9.1 Overview of Key Vendors 127 9.2 New Product Launch, Partnership, Investment, and M&A 130 9.3 Company Profiles 131 AbbVie Inc. 131 Astrazeneca 133 Aurobindo Pharma Ltd. 138 BASF 141 Bayer AG 144 Boehringer Ingelheim 148 Catalent Inc. 153 Dr. Reddy's Laboratories 156 F. Hoffmann-La Roche 158 GlaxoSmithKline plc 161 Lonza Group 166 Lupin Limited 170 Merck & Co., Inc. 173 Mylan NV 176 Novartis International AG 179 Pfizer Inc. 182 Sanofi 187 Sun Pharmaceutical Industries Ltd. 190 Teva Pharmaceutical Industries Ltd. 193 Thermo Fisher Scientific 195 Related Reports and Products 198
List of Tables: Table 1. Snapshot of Europe Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032 19 Table 2. World Economic Outlook, 2021-2031 23 Table 3. World Economic Outlook, 2021-2023 24 Table 4. Scenarios for Economic Impact of Ukraine Crisis 33 Table 5. World Health Spending by Region, $ bn, 2013-2020 42 Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 43 Table 7. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market 47 Table 8. Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn 55 Table 9. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 59 Table 10. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn 61 Table 11. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn 65 Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn 70 Table 13. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn 73 Table 14. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn 79 Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 82 Table 16. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn 84 Table 17. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn 88 Table 18. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn 91 Table 19. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 94 Table 20. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn 104 Table 21. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 111 Table 22. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 113 Table 23. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 113 Table 24. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 113 Table 25. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 115 Table 26. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 115 Table 27. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 115 Table 28. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 117 Table 29. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 117 Table 30. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 117 Table 31. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 120 Table 32. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 120 Table 33. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 120 Table 34. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 122 Table 35. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 122 Table 36. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 122 Table 37. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 124 Table 38. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 124 Table 39. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 124 Table 40. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn 126 Table 41. AbbVie Inc.: Company Snapshot 131 Table 42. AbbVie Inc.: Business Segmentation 132 Table 43. AbbVie Inc.: Product Portfolio 132 Table 44. Astrazeneca: Company Snapshot 133 Table 45. Aurobindo Pharma Ltd.: Company Snapshot 138 Table 46. Aurobindo Pharma Ltd.: Product Portfolio 139 Table 47. BASF: Company Snapshot 141 Table 48. BASF: Business Segmentation 142 Table 49. Bayer AG: Company Snapshot 144 Table 50. Bayer AG: Business Segmentation 145 Table 51. Bayer AG: Product Portfolio 145 Table 52. Boehringer Ingelheim: Company Snapshot 148 Table 53. Boehringer Ingelheim: Product Portfolio 149 Table 54. Catalent Inc.: Company Snapshot 153 Table 55. Catalent Inc.: Business Segmentation 154 Table 56. Catalent Inc.: Product Portfolio 154 Table 57. Dr. Reddy's Laboratories: Company Snapshot 156 Table 58. Dr. Reddy's Laboratories: Business Segmentation 156 Table 59. F. Hoffmann-La Roche: Company Snapshot 158 Table 60. F. Hoffmann-La Roche: Clinical Trial Service 158 Table 61. F. Hoffmann-La Roche: Business Segmentation 159 Table 62. F. Hoffmann-La Roche: Revenue by Region 159 Table 63. GlaxoSmithKline: Company Snapshot 161 Table 64. GlaxoSmithKline: Business Segmentation 162 Table 65. GlaxoSmithKline: Product Portfolio 163 Table 66. Lonza Group: Company Snapshot 166 Table 67. Lonza Group: Business Segmentation 167 Table 68. Lonza Group: Product Portfolio 167 Table 69. Lupin Limited: Company Snapshot 170 Table 70. Lupin Limited: Business Segmentation 171 Table 71. Merck & Co., Inc.: Company Snapshot 173 Table 72. Merck & Co., Inc.: Business Segmentation 174 Table 73. Mylan NV: Company Snapshot 176 Table 74. Mylan NV: Breakdown of Revenue by Region, 2022 177 Table 75. Mylan NV: Breakdown of Revenue by Product Category, 2022 177 Table 76. Novartis International AG: Company Snapshot 179 Table 77. Novartis International AG: Business Segmentation 180 Table 78. Pfizer Inc.: Company Snapshot 182 Table 79. Pfizer Inc.: Business Segmentation 183 Table 80. Pfizer Inc.: Breakdown of Revenue by Product Category 183 Table 81. Pfizer Inc.: Breakdown of Revenue by Region 184 Table 82. Pfizer Inc.: Product Portfolio 184 Table 83. Sanofi: Company Snapshot 187 Table 84. Sanofi: Business Segmentation 188 Table 85. Sanofi: Breakdown of Revenue by Region 188 Table 86. Sun Pharmaceutical Industries Limited: Company Snapshot 190 Table 87. Teva Pharmaceutical Industries Ltd.: Company Snapshot 193 Table 88. Teva Pharmaceutical Industries Ltd.: Business Segmentation 194 Table 89. Thermo Fisher Scientific: Company Snapshot 195 Table 90. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, 6 Table 91. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, 6
List of Figures: Figure 1. Research Method Flow Chart 13 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16 Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18 Figure 4. Europe Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 21 Figure 5. Impact of COVID-19 on Business 25 Figure 6. Primary Drivers and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 36 Figure 7. GDP per capita in the World, 1960-2022, $ thousand 39 Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 40 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 41 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 41 Figure 11. Primary Restraints and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 44 Figure 12. Investment Opportunity Analysis 48 Figure 13. Porter’s Fiver Forces Analysis of Europe Active Pharmaceutical Ingredients (API) Market 51 Figure 14. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue 56 Figure 15. Europe Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%) 56 Figure 16. Europe Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn 57 Figure 17. Europe Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn 58 Figure 18. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue 59 Figure 19. Contribution to Europe 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 60 Figure 20. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn 61 Figure 21. Europe Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn 62 Figure 22. Europe Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn 63 Figure 23. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn 64 Figure 24. Europe Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn 66 Figure 25. Europe Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn 67 Figure 26. Europe Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn 68 Figure 27. Europe Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn 69 Figure 28. Europe Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn 71 Figure 29. Europe Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn 72 Figure 30. Europe Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn 74 Figure 31. Europe Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn 75 Figure 32. Europe Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn 76 Figure 33. Europe Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn 77 Figure 34. Europe Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn 78 Figure 35. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn 79 Figure 36. Europe Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn 80 Figure 37. Europe Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn 81 Figure 38. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue 82 Figure 39. Contribution to Europe 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 83 Figure 40. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn 84 Figure 41. Europe Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn 85 Figure 42. Europe Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn 86 Figure 43. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn 87 Figure 44. Europe API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn 89 Figure 45. Europe API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn 90 Figure 46. Europe API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn 92 Figure 47. Europe API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn 93 Figure 48. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue 94 Figure 49. Contribution to Europe 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 95 Figure 50. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn 96 Figure 51. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn 97 Figure 52. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn 98 Figure 53. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn 99 Figure 54. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn 100 Figure 55. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn 101 Figure 56. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn 102 Figure 57. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn 103 Figure 58. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue 104 Figure 59. Contribution to Europe 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 105 Figure 60. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn 106 Figure 61. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn 107 Figure 62. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn 108 Figure 63. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 110 Figure 64. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 111 Figure 65. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn 112 Figure 66. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn 114 Figure 67. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn 116 Figure 68. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn 119 Figure 69. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn 121 Figure 70. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn 123 Figure 71. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn 125 Figure 72. Growth Stage of Europe Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 127 Figure 73. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022 134 Figure 74. AstraZeneca: Breakdown of Revenue by Region, 2022 134 Figure 75. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022 149 Figure 76. Boehringer Ingelheim: R&D Investement, 2019-2022 150
Selected Key Players: AbbVie Inc. Astrazeneca Aurobindo Pharma Ltd. BASF Bayer AG Boehringer Ingelheim Catalent Inc. Dr. Reddy's Laboratories F. Hoffmann-La Roche GlaxoSmithKline plc Lonza Group Lupin Limited Merck & Co., Inc. Mylan NV Novartis International AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)